Skip to main content

Healthcare & Biotech

Curaleaf Rebuts Aurora Cannabis Claims, Defends Takeover Premium

Stamford, Conn. – – September 11, 2026 -- Curaleaf Holdings, Inc. released a fact sheet countering what it called inaccurate statements by Aurora Cannabis Inc. regarding Curaleaf's proposal to acquire the company, arguing its offer represents one of the highest premiums in a decade of Canadian M&A.

Curaleaf says its bid carries a 110% premium once Aurora's cash is excluded

Curaleaf's headline offer reflects a 45% premium, which the company says ranks among the higher Canadian M&A premiums of the past ten years. Stripping out cash on Aurora's balance sheet, Curaleaf calculates the effective premium at 110%. Curaleaf noted Aurora has continued issuing shares through an At-the-Market program at prices below the value implied by the offer, even after the bid was made public.

SciBase Gets $0.6M Order From Castle Biosciences on AD Study

Stockholm – September 11, 2026 -- SciBase Holding AB (STO: SCIB) has received an additional order worth roughly $0.6 million, or approximately SEK 5 million, from Castle Biosciences (NASDAQ: CSTL) to accelerate an ongoing clinical study and prepare a second trial under their dermatology collaboration.

Order covers Nevisense Go devices and electrodes for atopic dermatitis research

The order includes both SciBase's portable Nevisense Go pen device and associated electrodes. Deliveries are scheduled to begin in the fourth quarter of 2026.

Collaboration targets relapse prediction in atopic dermatitis patients

SciBase and Castle Biosciences entered a collaboration and license agreement in 2025. The first joint study under that agreement aims to predict relapses in atopic dermatitis and is currently underway, with the new order funding both faster progression of that trial and groundwork for a follow-up study.

German Medical Association Backs Emergency Care Reform, Demands Changes

Berlin – September 11, 2026 -- Germany's Federal Medical Association (Bundesärztekammer) has confirmed support for a cross-sector reform of acute and emergency care, while pushing for amendments before the bill clears parliament.

Reinhardt calls for unified triage system across Germany

Association president Dr. Klaus Reinhardt told the Bundestag Health Committee ahead of a hearing on the draft law that the reform must introduce "genuine care management" needed across other healthcare sectors too. He said a nationwide, standardized initial assessment system is required to ensure patients are directed reliably through the system, with responsibility resting with physician self-governance bodies.

Micah Parsons Takes Equity Stake, Board Seat at RejuvStem

Dallas – September 11, 2026 -- NFL All-Pro Micah Parsons has taken an equity stake and board seat at RejuvStem, a Cancún, Mexico-based regenerative wellness company, as the firm looks to widen its footprint beyond athletic recovery into the broader preventive health market.

Parsons moves from endorsement to equity investor and board member

The deal, negotiated by Athletes First, the sports representation and marketing agency that handles Parsons' on- and off-field business, gives him formal roles as investor, board member and brand ambassador rather than a standard sponsorship arrangement. He will advise RejuvStem on brand growth and strategic initiatives, working to position the company's regenerative therapies and personalized wellness programs to a wider consumer base that includes non-athletes seeking preventive care.

IVI RMA North America Adds Illume Fertility, Expands Northeast Network

Hartford, Conn. – September 11, 2026 -- IVI RMA North America has partnered with Illume Fertility, adding the Connecticut-based provider's five clinics across Connecticut and New York to its regional network. The deal extends IVI RMA's existing Northeast footprint, which includes operations in Boston and New Jersey, into a more integrated multi-state fertility care corridor.

Illume brings nine board-certified specialists into the IVI RMA fold

Illume Fertility's clinical team consists of nine fertility specialists, each board-certified in reproductive endocrinology and infertility as well as obstetrics and gynecology. The physicians hold fellowship training in fertility treatment, hormone regulation, and assisted conception.

PulsePoint Extends NPI-Verified HCP Targeting to YouTube

Image
PulsePoint Extends NPI-Verified HCP Targeting to YouTube

New York – September 11, 2026 -- PulsePoint has expanded its Audience Manager platform to YouTube, enabling pharma and healthcare marketers to activate and measure verified, NPI-level physician audiences on the video platform for the first time.

Early campaigns show 1.9x higher click-through rates using verified targeting

In early activations, campaigns using Audience Manager target lists on YouTube generated a 1.9x higher click-through rate compared to broad demographic targeting, according to PulsePoint. The company's DirectMatch technology deterministically matches verified NPI audiences directly onto YouTube campaigns, addressing a gap where video platforms previously lacked prescriber-level precision for media buyers.

Cartwheel Launches Clinical Program Targeting Youth Screen Addiction

Image
Cartwheel Launches Clinical Program Targeting Youth Screen Addiction

Cambridge, Mass. -- September 8, 2026 -- Cartwheel, the largest school-centered telehealth provider in the U.S., has launched a Screens & Social Media Program to treat students whose sleep, mental health, and school performance are disrupted by digital device use.

Cartwheel clinicians identify escalating digital-stress patterns across nearly 400 school districts

The company reports clinicians have observed students losing sleep to phones, escalating family conflict over screen time, and social media reshaping how kids perceive themselves and peers. The program, in development since spring, was built to move beyond blanket screen-time limits toward individualized clinical treatment.

Hamburg Approves EU-Wide Tender for New Asklepios Altona Hospital

Image
Hamburg Approves EU-Wide Tender for New Asklepios Altona Hospital

Hamburg – September 11, 2026 -- Hamburg's Senate has approved the procedural framework for a new Asklepios Klinik Altona, clearing the way for a Europe-wide tender to build a 600-bed hospital serving more than 280,000 residents in western Hamburg.

Senate clears path for continent-wide procurement process

The city's Social Affairs Authority and Asklepios have agreed on key parameters covering planning and construction awards, project financing, supporting infrastructure and land provision. The Hamburg parliament (Bürgerschaft) will decide on final construction and equipment costs once tender results are in, with a vote expected by the end of 2027.

Highlands Community Services Featured on PBS Series on Rural Care

Image
Highlands Community Services Featured on PBS Series on Rural Care

Los Angeles – – September 11, 2026 -- Highlands Community Services, a regional behavioral health provider in Southwest Virginia, will be featured in an upcoming segment of the Public Television series "All Access hosted by Andy Garcia," spotlighting trauma-informed care models designed to close service gaps in rural mental health and addiction treatment.

Program targets justice-system diversion for behavioral health crises

The segment examines how sparse rural infrastructure often forces law enforcement officers to act as primary responders during acute psychiatric emergencies, a pattern that drives unnecessary arrests and strains public resources. Highlands Community Services details how direct referral pathways and trauma-informed training for first responders, educators and local agencies redirect individuals from the justice system into clinical treatment settings.

Insightec Hits 10,000 EMEA Patients Treated With Focused Ultrasound

Image
Insightec Hits 10,000 EMEA Patients Treated With Focused Ultrasound

Haifa/Frankfurt – September 11, 2026 -- Insightec has treated 10,000 patients across Europe, the Middle East and Africa with its Exablate Neuro platform for essential tremor and Parkinson's disease, a figure that has more than doubled over the past three years. The incisionless MR-guided focused ultrasound (MRgFUS) therapy is now available at more than 62 treatment centers in 20 countries across the region, part of a global network exceeding 30,000 patients treated at 226 centers worldwide.

Treatment volumes double in three years as adoption accelerates

The EMEA milestone caps a decade of expansion for focused ultrasound in the region, with hospitals increasingly offering the incisionless approach to patients whose only prior options were medication or invasive surgery. Growth spans both essential tremor and Parkinson's disease indications, according to Jake Ghannam, Executive Vice President and Chief Commercial Officer at Insightec.